The association between infarct artery size and clinical outcomes after percutaneous coronary intervention has not been characterized. We hypothesized that patients with large vessel infarction would have worse clinical outcomes. Methods: A total of 3,274 patients enrolled in the Korea Acute Myocardial Infarction Registry who underwent only one DES implantation for IRA were grouped according to infarct vessel diameter: group I (small vessel, implanted DES diameter Յ 2.75mm, Nϭ635, male 60.3%) and group II (large vessel (implanted DES diameter Ͼ2.75mm, Nϭ2,639, male 77.1%). Patients with multi-vessel or left-main disease were excluded. The primary endpoint was major adverse cardiac events (MACE), including death, MI, and target lesion revascularization at 12 months after percutaneous coronary intervention (PCI). Results: Patients in group I were older (62.4Ϯ12.4 vs. 58.6Ϯ12.5 years, pϽ0.001); had higher prevalence of diabetes (24.8 vs. 19.8%, pϭ0.009), hypertension (45.7 vs. 38.5%, pϭ0.001), and stenotic lesions in the left circumflex coronary artery (28.3 vs. 11.2%, pϽ0.001); and were more likely to have lower level of maximal troponin-I (37.8Ϯ71.7 vs. 55.9Ϯ112.7 ng/mL, pϭ0.001). There were no differences between the group in Killip classification, dyslipidemia, lesion characteristics, stent length, pre-and post-PCI Thrombolysis In Myocardial Infarction flow (TIMI). In-hospital mortality was higher in group I (3.0 vs. 1.4%, pϭ0.012). During follow-up, however, the rates of composite of MACE at 1, 6, 12 months were not statistically between the two groups. In multivariate analysis, Killip classՆII (odds ratio (OR), 8.358; 95% confidence interval (CI), 3.109 ϳ 22.466; pϭϽ0.001), ageϾ65 years (OR, 4.106; 95% CI, 1.287 ϳ 12.094; pϭ0.017), preprocedural TIMI flow grade 0 (OR, 2.802; 95% CI, 1.021 ϳ 7.693; pϭ0.045), ejection fraction Ͻ40% (OR, 7.042; 95% CI, 2.551 ϳ 19.607; pϽ0.001) were independent predictors of in-hospital mortality. Conclusions: Patients with small vessel infarction had similar angiographic and clinical outcomes, compared to those with large vessel infarction after PCI with DES during a 12-month clinical follow-up.
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The Background: The use of advanced imaging modalities for early determination of infarct size is limited in daily practice and therefore, it would be of particular use to estimate infarct size and prognosis by troponin (cTnT). Methods: The value of peak and serial 6h high-sensitive (hs) cTnT for estimation of infarct size as 48h cumulative CK release (Q48CK), LV function at 3 months as wall motion score index (WMSI) and LV ejection fraction (LVEF), and adverse clinical outcome as the composite of all-cause death, ICD implantation or hospitalization for heart failure, was studied in patients who underwent primary PCI for first STEMI. Results: In 188 consecutive patients (61Ϯ12 yrs, 72% men), peak and all fixed time hs-cTnT values were significantly correlated with Q48CK, WMSI and LVEF, of which the value at 24h after onset of symptoms (hs-cTnT24) demonstrated the best correlation (rϭ0.86, 0.47 and Ϫ0.59 [pϽ0.001], respectively). With the addition of hs-cTnT values separately to multivariate regression models, all were independent predictors of Q48CK, WMSI and LVEF but hs-cTnT24 was demonstrated to have the greatest impact on the outcomes with an increase in R2 of 0.51, 0.09 and 0.18 (pϽ0.001), respectively. Moreover, all cTnT values independently predicted adverse clinical outcome, of which hs-cTnT24 again showed the largest influence (HR 3.77 [95%CI 2.12-6.73], pϽ0.001, Figure) .
Conclusions: Not only peak, but all fixed time hs-cTnT values were predictive of infarct size, LV function 3 months and adverse clinical outcome 1 year after STEMI, particularly 24h after the onset of symptoms.
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Impact of Level of Physician Training on Transfer of ST Segment Elevation Myocardial Infarction
Edward O'Leary 1 , Loretta Pierce 2 , Scott Menolascino 2 , Nicole Keil 2 1 University of Nebraska Medical Center, Omaha, NE, 2 Omaha Veterans Administration Medical Center, Omaha, NE Background: Patients (pts) presenting with STEMI to facilities that do not perform PCI receive lytics and/or are transferred. AHA's Mission: Lifeline "Strategies for the Ideal STEMI-Referral Hospital" recommends Door In Door Out (DIDO) time within 30 minutes for the referring hospital (1). The Omaha Veterans Administration Medical Center (OVAMC) transfers pts presenting with STEMI to its affiliate, The Nebraska Medical Center (TNMC). These pts are treated/ transferred from the emergency room (ER) of the OVAMC by staff physicians and by residents/fellows after hours. A STEMI task force was formed at the OVAMC in the fall of 2011 to study the transfer process and outcomes of patients from the ER to TNMC. Methods: Multiple parameters were tracked including the (DIDO) time, initial EKG, medications, time of day, transportation and physicians. Significant protocol changes were put in place after the initial observation period from Dec 10, 2011 to Feb 2, 2012 (period 1). A STEMI monitoring committee was established at OVAMC. Data on DIDO was collected from Feb 11, 2011 to May 23, 2012 (period 2). Wilcoxon rank sum test was used to compare DIDO times between periods and p-values less than 0.05 are statistically significant. Results: Median DIDO times significantly decreased from period 1 to period 2 in all groups. Staff physicians(SP)had significantly lower DIDO than resident/fellow (R/F)in period 2 (pϭ0.0018)( 
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Percutaneous, trans-endocardial injection of bone marrow derived mononuclear cells significantly improves left ventricular ejection fraction in patients following acute myocardial infarction: ALSTER Stem cell trial
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